BNP Paribas Financial Markets
NUVB icon

BNP Paribas Financial Markets’s Nuvation Bio NUVB Stock Holding History

BNP Paribas Financial Markets’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$881K Sell
205,454
-496,563
-71% -$2.77M ﹤0.01% 3227
2025
Q4 		$6.29M Buy
702,017
+650,316
+1,258% +$4.03M ﹤0.01% 1891
2025
Q3 		$191K Buy
51,701
+23,549
+84% +$64.2K ﹤0.01% 4029
2025
Q2 		$54.9K Buy
28,152
+14,989
+114% +$31.2K ﹤0.01% 4228
2025
Q1 		$23.2K Sell
13,163
-10,868
-45% -$24.7K ﹤0.01% 4498
2024
Q4 		$63.9K Buy
+24,031
New +$61.9K ﹤0.01% 4330
2022
Q4 		– Sell
-70,447
Closed -$158K – 4419
2022
Q3 		$158K Buy
+70,447
New +$201K ﹤0.01% 3588

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets's NUVB Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Nuvation Bio (NUVB) stake by 71% in Q1 2026, selling an estimated $2.77M and leaving 205,454 shares worth $881K. The position accounts for ﹤0.01% of the portfolio, ranked #3227.

BNP Paribas Financial Markets first reported a position in NUVB in Q3 2022 and has held it in 7 quarters since. The position peaked at $6.29M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • BNP Paribas Financial Markets held 205,454 shares of Nuvation Bio worth $881K as of Q1 2026.
  • BNP Paribas Financial Markets sold 496,563 Nuvation Bio shares in Q1 2026, an estimated $2.77M.
  • Nuvation Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3227 holding.
  • BNP Paribas Financial Markets first reported a position in Nuvation Bio in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Nuvation Bio position peaked at $6.29M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.